American Century Companies’s Aurinia Pharmaceuticals AUPH Stock Holding History

American Century Companies's AUPH Position: Q2 2026 in Review

American Century Companies reduced its Aurinia Pharmaceuticals (AUPH) stake by 2.6% in Q2 2026, selling an estimated $154K and leaving 355,572 shares worth $6.03M. The position accounts for ﹤0.01% of the portfolio, ranked #1801.

American Century Companies first reported a position in AUPH in Q1 2023 and has held it in 10 quarters since. The position peaked at $6.43M in Q4 2025. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

• American Century Companies held 355,572 shares of Aurinia Pharmaceuticals worth $6.03M as of Q2 2026.
• American Century Companies sold 9,664 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $154K.
• Aurinia Pharmaceuticals made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #1801 holding.
• American Century Companies first reported a position in Aurinia Pharmaceuticals in Q1 2023 and has held it in 10 quarters since.
• American Century Companies's Aurinia Pharmaceuticals position peaked at $6.43M in Q4 2025.
• 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.